Immunogenicity and safety of a tetravalent recombinant subunit dengue vaccine in adults previously vaccinated with a live attenuated tetravalent dengue vaccine: Results of a phase-I randomized clinical trial
Anna P. Durbin, Kristen K. Pierce, Beth D. Kirkpatrick, Palmtama Grier, Beulah P. Sabundayo, Helen He, Michele Sausser, Amy Falk Russell, Jason Martin, Donna Hyatt, Melissa Cook, Jeffrey R. Sachs, Andrew Wen Tseng Lee, Liman Wang, Beth Ann Coller, Stephen S. Whitehead
Dive into the research topics of 'Immunogenicity and safety of a tetravalent recombinant subunit dengue vaccine in adults previously vaccinated with a live attenuated tetravalent dengue vaccine: Results of a phase-I randomized clinical trial'. Together they form a unique fingerprint.